Home > PS Ratio > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
PS (Price/Sales) Ratio

The Current P/S Ratio of SAMRAT PHARMACHEM is 0.39.

Share Price ₹375.7Dec 26,2024
Market Cap ₹116.5 Cr
Sales-TTM₹295.4 CrTTM-Standalone Results
Price/Sales0.39xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results
SAMRAT PHARMACHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SAMRAT PHARMACHEM

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SAMRAT PHARMACHEM is calculated as :

Current Market Cap [ ₹116.5 Cr] as on Dec 26,2024

(/) Sales [ ₹295.4 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 0.39x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SAMRAT PHARMACHEM , the investors are currently willing to pay '0.39 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SAMRAT PHARMACHEM !

The chart below summarizes the trend in P/S Ratio of SAMRAT PHARMACHEM over the last five years.

Historical PS (Price/Sales) ratio chart of SAMRAT PHARMACHEM


PS Ratio Performance Analysis for SAMRAT PHARMACHEM

- SAMRAT PHARMACHEM 's latest p/e ratio is 0.39x.

- SAMRAT PHARMACHEM 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.36x.

- SAMRAT PHARMACHEM 's operated at median p/e ratio of 0.37x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SAMRAT PHARMACHEM 's p/e ratio peaked in Mar2022 at 0.68x.

- SAMRAT PHARMACHEM 's p/e ratio hit its five-year low in Mar2020 of 0.13x.


How does SAMRAT PHARMACHEM 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SAMRAT PHARMACHEM 295.40.39116.5
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.78441,838.0
CIPLA LTD26,512.04.54120,270.0
DR REDDYS LABORATORIES LTD30,084.93.76113,077.0
ZYDUS LIFESCIENCES LTD21,483.54.4996,553.2
DIVIS LABORATORIES LTD8,614.018.12156,107.0
MANKIND PHARMA LTD11,018.010.91120,212.0
TORRENT PHARMACEUTICALS LTD11,225.010.30115,643.0
LUPIN LTD21,431.34.6499,532.1
AUROBINDO PHARMA LTD30,295.02.4172,945.8
ABBOTT INDIA LTD6,066.110.0360,844.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SAMRAT PHARMACHEM 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 0.39x
Max industry PS 18.12x
Median industry PS 4.64x
Average industry PS 7.13x



You may also like the below Video Courses